hydrochlorothiazide has been researched along with Antiphospholipid Syndrome in 3 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
Antiphospholipid Syndrome: The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Systemic lupus erythematosus is a disease of unknown cause that manifests with tissue and cellular alterations due to the deposition of antibodies and pathogenic immune complexes." | 2.43 | Sudden sensorineural hearing loss in lupus erythematosus associated with antiphospholipid syndrome: case report and review. ( Brandolini, C; Compadretti, GC; Tasca, I, 2005) |
| "Antiphospholipid syndrome is an autoimmune disease that presents with recurrent arteriovenous thrombosis, repeated pregnancy loss and elevated titres of antiphospholipid antibodies in the blood." | 1.36 | Antiphospholipid syndrome in childhood systemic lupus erythematosus. ( Paudyal, B, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerosa, M | 1 |
| Meroni, PL | 1 |
| Erkan, D | 1 |
| Paudyal, B | 1 |
| Compadretti, GC | 1 |
| Brandolini, C | 1 |
| Tasca, I | 1 |
2 reviews available for hydrochlorothiazide and Antiphospholipid Syndrome
| Article | Year |
|---|---|
Recognition and management of antiphospholipid syndrome.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; | 2016 |
Sudden sensorineural hearing loss in lupus erythematosus associated with antiphospholipid syndrome: case report and review.
Topics: Adult; Antiphospholipid Syndrome; Diuretics; Female; Glycerol; Hearing Loss, Sudden; Humans; Hydroch | 2005 |
1 other study available for hydrochlorothiazide and Antiphospholipid Syndrome
| Article | Year |
|---|---|
Antiphospholipid syndrome in childhood systemic lupus erythematosus.
Topics: Adolescent; Antihypertensive Agents; Antiphospholipid Syndrome; Female; Glucocorticoids; Heparin; Hu | 2010 |